Obese Women Have Higher Risk Of Suffering Breast Cancer

Key points
- Obese women develop breast cancer at a younger age than other women.
- The University of Granada researchers found that women diagnosed with breast cancer at an earlier age were those who started menstruating when younger than 10 years.
- This is one of the main conclusions drawn in an article recently published in the Spanish journal Nutrición Hospitalaria by the University of Granada research group CTS 367, coordinated by the Nursery Department professor María José Aguilar Cordero.
- The researchers examined a sample of 524 women diagnosed with breast cancer who were treated at the university hospital San Cecilio from January 2009 to September 2010 in Granada, Spain.
Obese women develop breast cancer at a younger age than other women. Furthermore, the likelihood of developing breast cancer is much higher in patients with morbid obesity.
This is one of the main conclusions drawn in an article recently published in the Spanish journal Nutrición Hospitalaria by the University of Granada research group CTS 367, coordinated by the Nursery Department professor María José Aguilar Cordero.
The researchers examined a sample of 524 women diagnosed with breast cancer who were treated at the university hospital San Cecilio from January 2009 to September 2010 in Granada, Spain. They assessed the nutritional status of these patients (normal weight, obesity and morbid obesity) and their age at diagnosis. Women with a family history of breast cancer were separated from those lacking it.
The researchers found that obesity in women is associated with diagnosis of breast cancer at a younger age. This finding contrasts with the results obtained in previous studies that demonstrated that individuals with higher body mass index had lower risk of suffering breast cancer.
Age At First Menstruation
The University of Granada researchers found that women diagnosed with breast cancer at an earlier age were those who started menstruating when younger than 10 years. Thus, age at menarche is determinant in the development and diagnosis of breast cancer, especially in women with morbid obesity.
Therefore, although genetics and family history of cancer are very relevant factors (up to 18% of breast cancer in obese women had a genetic factor), this study proved that obesity -especially the most severe cases- is the most relevant factor in early development of breast cancer.
Contacting Person: Mª José Aguilar Cordero. University of Granada Nursery Universidad de Granada. Phone Number: +34 958242897. E-mail: [email protected]
###
University of Granada researchers have proven that overweight women -especially those with morbid obesity- develop this disease at an earlier age.
A total of 524 women with breast cancer participated in the study. The researchers found that women who started menstruating at a very early age –between 9 and 10 years- developed breast cancer at a younger age.
###
Universidad de Granada
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsBreast cancer risk related to changes in breast density as women age
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research being…
3 December 2013
NewsStudy finds link between allergies and increased risk of blood cancers in women
A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies - in particular to plants, grass and trees - with risk of blood cancers in women.…
23 November 2013
NewsHigher than normal levels of Vitamin B12 may indicate cancer risk
Vitamin B12 (cobalamin [Cbl]) is essential for maintaining healthy bodily function but higher than normal levels (reference range 200-600 pmol/L) may indicate that a patient is at risk of developing certain cancers,…







